Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Aromatic L-Amino Acid Decarboxylase Deficiency

Neurological & Neuromuscular

Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) Clinical Trials

Also called AADC Deficiency, Aromatic Amino Acid Decarboxylase Deficiency, DDC Deficiency, AADCD

Aromatic L-Amino Acid Decarboxylase (AADC) deficiency is a neurometabolic disorder caused by pathogenic variants in the DDC gene, which encodes an enzyme responsible for producing several critical neurotransmitters. These include dopamine, serotonin, and related molecules that regulate movement, mood, sleep, and autonomic body functions. When the AADC enzyme doesn't work properly, the brain cannot produce adequate amounts of these essential chemicals.

In plain words, AADC deficiency is a rare inherited condition where the brain cannot make enough dopamine and serotonin, chemicals that guide movement and mood. Starting in infancy, it causes low muscle tone and delayed development as well as eyes that roll upward on their own.

Get an email when new Aromatic L-Amino Acid Decarboxylase Deficiency trials open or the FDA decides. Get alerts

Aromatic L-Amino Acid Decarboxylase Deficiency

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 1 study with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines1

Kebilidi

Aromatic L-Amino Acid Decarboxylase Deficiency has 1 FDA-approved medicine, 3 open or active clinical trials (3 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

More about Aromatic L-Amino Acid Decarboxylase Deficiency

Infants with AADC deficiency typically show signs within the first 6 months of life, starting with feeding difficulties and low muscle tone. As they grow, they develop characteristic oculogyric crises (involuntary upward-rolling eye movements), severe developmental delays, and progressive movement disorders. Many also experience significant autonomic dysfunction, including excessive sweating, difficulty regulating body temperature, and blood pressure fluctuations.

Keep reading about Aromatic L-Amino Acid Decarboxylase Deficiency

Diagnosis involves genetic testing for DDC gene variants and cerebrospinal fluid analysis showing abnormal neurotransmitter levels. A major breakthrough came with FDA accelerated approval of Kebilidi (eladocagene exuparvovec-tneq) in November 2024, a gene therapy that delivers a healthy copy of the DDC gene directly into the brain.

What are the symptoms of Aromatic L-Amino Acid Decarboxylase Deficiency?

These are common symptoms of Aromatic L-Amino Acid Decarboxylase Deficiency, and how strong they are varies from person to person.

  • Low muscle tone (hypotonia) and poor feeding
  • Involuntary upward-rolling eye movements (oculogyric crises)
  • Developmental delays and intellectual disability
  • Movement disorders including dystonia
  • Autonomic dysfunction: excessive sweating, temperature instability, drooping eyelids
  • Sleep disturbances and mood changes including irritability

Who gets Aromatic L-Amino Acid Decarboxylase Deficiency?

AADC deficiency typically appears in infancy, with symptoms emerging within the first 6 months of life. The condition follows autosomal recessive inheritance, meaning both parents must carry a variant in the DDC gene. It affects males and females equally and is more prevalent in people of Asian descent, particularly those with ancestry from Taiwan, Japan, and China.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for Aromatic L-Amino Acid Decarboxylase Deficiency?

There is currently 1 FDA-approved medication for Aromatic L-Amino Acid Decarboxylase Deficiency.

eladocagene exuparvovec-tneq
PTC Therapeutics
Search

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Aromatic L-Amino Acid Decarboxylase Deficiency treatment

Charity funds and drugmaker programs for Aromatic L-Amino Acid Decarboxylase Deficiency, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Open the full patient assistance finder →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Aromatic L-Amino Acid Decarboxylase Deficiency

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Aromatic L-Amino Acid Decarboxylase Deficiency resources

Reputable organizations and medical references for learning more about Aromatic L-Amino Acid Decarboxylase Deficiency, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Aromatic L-Amino Acid Decarboxylase Deficiency

Use this Aromatic L-Amino Acid Decarboxylase Deficiency clinical trial finder to see the 3 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. Of these, 2 test a treatment and 1 is an observational study or registry; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

3 active trials worldwide
Filter:
Sort:
RecruitingObservational study, no treatment givenRecently updatedNCT07877714

Newborn Screening and Early Diagnosis of AADC Deficiency in the Ligurian Population

Sponsor: Istituto Giannina Gaslini

Aromatic L-amino acid decarboxylase deficiency (AADC-D) is a rare genetic disorder that affects the production of neurotransmitters in the brain and can cause severe neurological and developmental problems. Early diagnosis may allow affected children to be referred promptly for s...

Ages 0 Days to 3 Days
Started Aug 2023Updated 1 month agoEst. Dec 2025
RecruitingTreatment trialPhase 1Recently updatedNCT02852213

A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

Intervention: AAV2-hAADC

Sponsor: Krzysztof Bankiewicz

The overall objective of this study is to determine the safety and efficacy of AAV2-hAADC delivered to the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) in children with aromatic L-amino acid decarboxylase (AADC) deficiency.

Ages 24 Months+3 locations
Started Jul 2016Updated 2 months agoEst. Aug 2027 (~9 months)
RecruitingTreatment trialEarly Phase 1Hasn't posted an update in over a yearNCT05765981

An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.

Intervention: VGN-R09b

Sponsor: Shanghai Jiao Tong University School of Medicine · Shanghai Vitalgen BioPharma Co., Ltd.

This early Phase trial is to prove the safety and efficacy of VGN-R09b to treat patients with AADC deficiency.

Ages 24 Months to 7 Years1 location
Started Jan 2023Updated 3 years agoEst. Feb 2025
Find Aromatic L-Amino Acid Decarboxylase Deficiency trials near you, ranked by distance →
Active trial locations2 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Early Phase 1
Phase 1
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Aromatic L-Amino Acid Decarboxylase Deficiency trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run an Aromatic L-Amino Acid Decarboxylase Deficiency foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Aromatic L-Amino Acid Decarboxylase Deficiency patient communities

Facebook groups, Reddit communities and YouTube channels where Aromatic L-Amino Acid Decarboxylase Deficiency patients, caregivers and advocacy groups talk.

Companies developing Aromatic L-Amino Acid Decarboxylase Deficiency treatments

Drugmakers that list Aromatic L-Amino Acid Decarboxylase Deficiency in their rare disease portfolio, 1 in all.

Questions people ask about Aromatic L-Amino Acid Decarboxylase Deficiency